Report Detail

Request for Sample of this report

Other Global mRNA Vaccine And Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3808096
    • |
  • 13 August, 2024
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global mRNA Vaccine And Therapeutics market size was valued at USD 37740 million in 2023 and is forecast to a readjusted size of USD 52020 million by 2030 with a CAGR of 4.7% during review period.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the mRNA Vaccine And Therapeutics industry chain, the market status of Hospital (Infectious Disease, Cancer), Research Institual (Infectious Disease, Cancer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA Vaccine And Therapeutics.
Regionally, the report analyzes the mRNA Vaccine And Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA Vaccine And Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA Vaccine And Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA Vaccine And Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Infectious Disease, Cancer).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA Vaccine And Therapeutics market.
Regional Analysis: The report involves examining the mRNA Vaccine And Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA Vaccine And Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA Vaccine And Therapeutics:
Company Analysis: Report covers individual mRNA Vaccine And Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA Vaccine And Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Research Institual).
Technology Analysis: Report covers specific technologies relevant to mRNA Vaccine And Therapeutics. It assesses the current state, advancements, and potential future developments in mRNA Vaccine And Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA Vaccine And Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA Vaccine And Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Infectious Disease
Cancer
Others
Market segment by Application
Hospital
Research Institual
Market segment by players, this report covers
Argos Therapeutics
BioNTech
CureVac
eTheRNA
Ethris
In-Cell-Art
Moderna Therapeutics
Sangamo Therapeutics
Tiba Biotechnology
Translate Bio
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Vaccine And Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Vaccine And Therapeutics, with revenue, gross margin and global market share of mRNA Vaccine And Therapeutics from 2019 to 2024.
Chapter 3, the mRNA Vaccine And Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and mRNA Vaccine And Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Vaccine And Therapeutics.
Chapter 13, to describe mRNA Vaccine And Therapeutics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of mRNA Vaccine And Therapeutics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of mRNA Vaccine And Therapeutics by Type
    • 1.3.1 Overview: Global mRNA Vaccine And Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global mRNA Vaccine And Therapeutics Consumption Value Market Share by Type in 2023
    • 1.3.3 Infectious Disease
    • 1.3.4 Cancer
    • 1.3.5 Others
  • 1.4 Global mRNA Vaccine And Therapeutics Market by Application
    • 1.4.1 Overview: Global mRNA Vaccine And Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Research Institual
  • 1.5 Global mRNA Vaccine And Therapeutics Market Size & Forecast
  • 1.6 Global mRNA Vaccine And Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global mRNA Vaccine And Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global mRNA Vaccine And Therapeutics Market Size by Region, (2019-2030)
    • 1.6.3 North America mRNA Vaccine And Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe mRNA Vaccine And Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific mRNA Vaccine And Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.6 South America mRNA Vaccine And Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa mRNA Vaccine And Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Argos Therapeutics
    • 2.1.1 Argos Therapeutics Details
    • 2.1.2 Argos Therapeutics Major Business
    • 2.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Product and Solutions
    • 2.1.4 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Argos Therapeutics Recent Developments and Future Plans
  • 2.2 BioNTech
    • 2.2.1 BioNTech Details
    • 2.2.2 BioNTech Major Business
    • 2.2.3 BioNTech mRNA Vaccine And Therapeutics Product and Solutions
    • 2.2.4 BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 BioNTech Recent Developments and Future Plans
  • 2.3 CureVac
    • 2.3.1 CureVac Details
    • 2.3.2 CureVac Major Business
    • 2.3.3 CureVac mRNA Vaccine And Therapeutics Product and Solutions
    • 2.3.4 CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CureVac Recent Developments and Future Plans
  • 2.4 eTheRNA
    • 2.4.1 eTheRNA Details
    • 2.4.2 eTheRNA Major Business
    • 2.4.3 eTheRNA mRNA Vaccine And Therapeutics Product and Solutions
    • 2.4.4 eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 eTheRNA Recent Developments and Future Plans
  • 2.5 Ethris
    • 2.5.1 Ethris Details
    • 2.5.2 Ethris Major Business
    • 2.5.3 Ethris mRNA Vaccine And Therapeutics Product and Solutions
    • 2.5.4 Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Ethris Recent Developments and Future Plans
  • 2.6 In-Cell-Art
    • 2.6.1 In-Cell-Art Details
    • 2.6.2 In-Cell-Art Major Business
    • 2.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Product and Solutions
    • 2.6.4 In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 In-Cell-Art Recent Developments and Future Plans
  • 2.7 Moderna Therapeutics
    • 2.7.1 Moderna Therapeutics Details
    • 2.7.2 Moderna Therapeutics Major Business
    • 2.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Product and Solutions
    • 2.7.4 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Moderna Therapeutics Recent Developments and Future Plans
  • 2.8 Sangamo Therapeutics
    • 2.8.1 Sangamo Therapeutics Details
    • 2.8.2 Sangamo Therapeutics Major Business
    • 2.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Product and Solutions
    • 2.8.4 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Sangamo Therapeutics Recent Developments and Future Plans
  • 2.9 Tiba Biotechnology
    • 2.9.1 Tiba Biotechnology Details
    • 2.9.2 Tiba Biotechnology Major Business
    • 2.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Product and Solutions
    • 2.9.4 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Tiba Biotechnology Recent Developments and Future Plans
  • 2.10 Translate Bio
    • 2.10.1 Translate Bio Details
    • 2.10.2 Translate Bio Major Business
    • 2.10.3 Translate Bio mRNA Vaccine And Therapeutics Product and Solutions
    • 2.10.4 Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Translate Bio Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global mRNA Vaccine And Therapeutics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of mRNA Vaccine And Therapeutics by Company Revenue
    • 3.2.2 Top 3 mRNA Vaccine And Therapeutics Players Market Share in 2023
    • 3.2.3 Top 6 mRNA Vaccine And Therapeutics Players Market Share in 2023
  • 3.3 mRNA Vaccine And Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 mRNA Vaccine And Therapeutics Market: Region Footprint
    • 3.3.2 mRNA Vaccine And Therapeutics Market: Company Product Type Footprint
    • 3.3.3 mRNA Vaccine And Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global mRNA Vaccine And Therapeutics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global mRNA Vaccine And Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global mRNA Vaccine And Therapeutics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global mRNA Vaccine And Therapeutics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America mRNA Vaccine And Therapeutics Consumption Value by Type (2019-2030)
  • 6.2 North America mRNA Vaccine And Therapeutics Consumption Value by Application (2019-2030)
  • 6.3 North America mRNA Vaccine And Therapeutics Market Size by Country
    • 6.3.1 North America mRNA Vaccine And Therapeutics Consumption Value by Country (2019-2030)
    • 6.3.2 United States mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe mRNA Vaccine And Therapeutics Consumption Value by Type (2019-2030)
  • 7.2 Europe mRNA Vaccine And Therapeutics Consumption Value by Application (2019-2030)
  • 7.3 Europe mRNA Vaccine And Therapeutics Market Size by Country
    • 7.3.1 Europe mRNA Vaccine And Therapeutics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.3 France mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific mRNA Vaccine And Therapeutics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific mRNA Vaccine And Therapeutics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific mRNA Vaccine And Therapeutics Consumption Value by Region (2019-2030)
    • 8.3.2 China mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.5 India mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America mRNA Vaccine And Therapeutics Consumption Value by Type (2019-2030)
  • 9.2 South America mRNA Vaccine And Therapeutics Consumption Value by Application (2019-2030)
  • 9.3 South America mRNA Vaccine And Therapeutics Market Size by Country
    • 9.3.1 South America mRNA Vaccine And Therapeutics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa mRNA Vaccine And Therapeutics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa mRNA Vaccine And Therapeutics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa mRNA Vaccine And Therapeutics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE mRNA Vaccine And Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 mRNA Vaccine And Therapeutics Market Drivers
  • 11.2 mRNA Vaccine And Therapeutics Market Restraints
  • 11.3 mRNA Vaccine And Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 mRNA Vaccine And Therapeutics Industry Chain
  • 12.2 mRNA Vaccine And Therapeutics Upstream Analysis
  • 12.3 mRNA Vaccine And Therapeutics Midstream Analysis
  • 12.4 mRNA Vaccine And Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on mRNA Vaccine And Therapeutics. Industry analysis & Market Report on mRNA Vaccine And Therapeutics is a syndicated market report, published as Global mRNA Vaccine And Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of mRNA Vaccine And Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo